EDITORIAL TOPICS
Published: November 2023
DIABETES RESEARCH
Comparison of early postoperative results in patients with and without diabetes
Effect of insulin resistance on left ventricular remodelling in essential hypertensives: a crosssectional study
Impact of diabetes mellitus on the frequency of postoperative complications after carotid endarterectomy
Prevalence of the metabolic syndrome among Botswana adults in Gaborone
Effect of insulin resistance on left ventricular remodelling in essential hypertensives: a crosssectional study
Impact of diabetes mellitus on the frequency of postoperative complications after carotid endarterectomy
Prevalence of the metabolic syndrome among Botswana adults in Gaborone
Published: November 2023
REVIEW ARTICLES
The cardiovascular benefits of new diabetes drugs
SGLT-2 inhibitors in type 2 diabetes
Profile, bacteriology and antibiotic susceptibility pattern of diabetic foot ulcers at the Federal Medical Centre, Makurdi, Nigeria
Cardiovascular disease risk assessment in Nigerian adults with type 2 diabetes or the metabolic syndrome, using the Framingham risk score
SGLT-2 inhibitors in type 2 diabetes
Profile, bacteriology and antibiotic susceptibility pattern of diabetic foot ulcers at the Federal Medical Centre, Makurdi, Nigeria
Cardiovascular disease risk assessment in Nigerian adults with type 2 diabetes or the metabolic syndrome, using the Framingham risk score
Published: November 2023
FOR THE DIABETIC PATIENT
Published: July 2019
ABOUT SA JOURNAL OF DIABETES AND
VASCULAR DISEASE
The South African Journal of
Diabetes & Vascular Disease aims to provide a
competent resource for specialists, general
practitioners and primary care diabetic nurse and
allied professionals on diabetes management in
Southern Africa.
The Journal publish original articles from South Africa and Southern Africa, which contribute towards the understanding of the particular problems facing our resource-constrained environment. All original articles will be subjected to peer-review. The types of articles include original research contributions of either clinical or basic laboratory research, epidemiology and case reports.
Important Notice to all Authors:
Manuscript Submission Fee & Article Processing Charge (effective 13 December 2016)
Reviews should be critical and relevant to our region. The categories of articles include Original Research, Reviews, CME Updates, Case Reports & Editorials relevant to the field of Diabetes (Type
1 and 2 Diabetes) and Vascular Disease, including strokes.
The payment of the manuscript submission fee and does not guarantee publication of the article. The manuscript submission fee is not refundable in the event of rejection as processing cost will have been incurred.
The Journal publish original articles from South Africa and Southern Africa, which contribute towards the understanding of the particular problems facing our resource-constrained environment. All original articles will be subjected to peer-review. The types of articles include original research contributions of either clinical or basic laboratory research, epidemiology and case reports.
Important Notice to all Authors:
Manuscript Submission Fee & Article Processing Charge (effective 13 December 2016)
Reviews should be critical and relevant to our region. The categories of articles include Original Research, Reviews, CME Updates, Case Reports & Editorials relevant to the field of Diabetes (Type
1 and 2 Diabetes) and Vascular Disease, including strokes.
-
Manuscript Submission Fee: South
African and International Authors: ZAR 500.
Paid on Submission of Manuscript.
-
Article Processing/Publishing Fee:
South African and International Authors: ZAR
1000.
Paid on Article Acceptance for Publication in the journal.
The payment of the manuscript submission fee and does not guarantee publication of the article. The manuscript submission fee is not refundable in the event of rejection as processing cost will have been incurred.
LATEST SA DIABETES & VASCULAR journal
ARTICLES
CURRENT ISSUE: VOLUME 20, ISSUE 2, NOVEMBER 2023
- Early postoperative results with and without diabetes after CABG
- The cardiovascular benefits of new diabetes drugs
- The importance of exercise in people living with diabetes
This journal is now available to be viewed via our eJournal publication viewer. PREVIOUS ISSUE: VOLUME 20, ISSUE 1, JUNE 2023
- Empagliflozin significantly prevents QTc prolongation due to amitriptyline intoxication
- Effect of insulin resistance on left ventricular remodelling in essential hypertensives
- Potential benefits of cinnamon for type 2 diabetes
- Painkillers linked to heart failure in type 2 diabetes: Danish study
This journal is now available to be viewed via our eJournal publication viewer.
diabetes news
American Diabetes Association updates its Standards of Medical Care for 2022
The American Diabetes Association (ADA) updated its Standards of Medical Care supplement in December, to provide clinicians, researchers, policy makers and other interested individuals with the components of diabetes care, general treatment goals and tools to evaluate the quality of care.
Read full article free online »
New research holds big promise for a type 1 diabetes cure
An experimental implant containing stem cells designed to mature into insulin-secreting cells passed its first human trails. The studies reported the implant (designed to replace the missing insulin cells) to be mildly effective, offering promising signs of a ‘functional cure’ for diabetics with type 1 diabetes.
Read full article free online »
The American Diabetes Association (ADA) updated its Standards of Medical Care supplement in December, to provide clinicians, researchers, policy makers and other interested individuals with the components of diabetes care, general treatment goals and tools to evaluate the quality of care.
Read full article free online »
New research holds big promise for a type 1 diabetes cure
An experimental implant containing stem cells designed to mature into insulin-secreting cells passed its first human trails. The studies reported the implant (designed to replace the missing insulin cells) to be mildly effective, offering promising signs of a ‘functional cure’ for diabetics with type 1 diabetes.
Read full article free online »
CALL FOR diabetes and vascular
original research ARTICLES
This peer-reviewed journal is
available as full text at all tertiary institutions
in South Africa, presenting a great opportunity to
submit your good-quality original articles for
speedy publication. Recent user research has shown
that some 10 000 annual topic searches were done on
the SA Journal of Diabetes & Vascular Disease
database, which contains seven years of published
material.
The SA Journal of Diabetes & Vascular Disease aims to provide a forum for specialists involved in the care of people with diabetes, to exchange information, promote better management and stimulate research in Africa.
This quarterly journal publishes original research and scholarly reviews about prevention and management of diabetes, relating to both general and specific issues. The SA Journal of Diabetes & Vascular Disease invites you to submit your articles online only.
Read the Instructions to Authors for more information on the journal’s policies and the submission process.
The SA Journal of Diabetes & Vascular Disease aims to provide a forum for specialists involved in the care of people with diabetes, to exchange information, promote better management and stimulate research in Africa.
This quarterly journal publishes original research and scholarly reviews about prevention and management of diabetes, relating to both general and specific issues. The SA Journal of Diabetes & Vascular Disease invites you to submit your articles online only.
Read the Instructions to Authors for more information on the journal’s policies and the submission process.
RELIABLE EXPERT INFORMATION
The SAJDVD’s main focus is
providing new and relevant information for doctors,
nurses and allied professionals involved in caring
for the diabetes patient.
But as we are part of the larger Diabetes team, we would like to reach out to all patients with relevant information. So here it is!
But as we are part of the larger Diabetes team, we would like to reach out to all patients with relevant information. So here it is!